Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results. Glitza Oliva IC, Ferguson SD, Bassett R Jr, Foster AP, et al. Nat Med 2023;29:898-905.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Glitza Oliva IC, Ferguson SD, Bassett R Jr, Foster AP, et al. Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results. Nat Med 2023;29:898-905.
PMID: 36997799